Associated Papers
Expression signature based on TP53 target genes doesn't predict response to TP53-MDM2 inhibitor in wild type TP53 tumors.
Sonkin D
Elife, 2015
26491944 (PubMed )
Supplement: elife-10279-supp1.xls › Supplemental_File_1E
Select a paper to view details